Frontiers in Human Neuroscience
2024
Beatrix Krause-Sorio, Sergio Becerra, Prabha Siddarth et al.
1 citation
Exposure to art, nature, or meditation, all transcending human experiences, has beneficial effects on health and wellbeing. Focusing inward or watching art and nature videos elicits positive emotions that can help heal stress-related conditions. In a pilot functional magnetic resonance (fMRI) study, we explored the effect of watching digital art or nature videos compared to contemplating the...
Frontiers in Psychology
2024
Thurston Lacalli
7 citations
The functions of consciousness, viewed from an evolutionary standpoint, can be categorized as being either general or particular. There are two general functions, meaning those that do not depend on the particulars of how consciousness influences behavior or how and why it first evolved: of (1) expanding the behavioral repertoire of the individual through the gradual accumulation of...
PLoS One
2024
Nicholas Hagger-Vaughan, Daniel Kolnier, Johan F. Storm
2 citations
Here we describe a type of depolarising plateau potentials (PPs; sustained depolarisations outlasting the stimuli) in layer 2/3 pyramidal cells (L2/3PC) in rat prefrontal cortex (PFC) slices, using whole-cell somatic recordings. To our knowledge, this PP type has not been described before. In particular, unlike previously described plateau potentials that originate in the large apical dendrite...
Neuroscience Applied
2024
Isabelle Straumann, Friederike Holze, Laura Ley et al.
24 citations
Psilocybin is being studied for its therapeutic potential in various mental health disorders, such as depression, anxiety, and addiction. Initial studies suggested that psilocybin is generally safe when used under controlled conditions, but more research is needed to better understand its safety profile. We report safety pharmacology data from a pooled analysis of three randomized crossover...
Journal of Indira Gandhi Institute Of Medical Sciences
2024
Rakesh Khanna
1 citation
Abstract A review of the literature on posttraumatic stress disorder (PTSD) suggests it to be a complex disorder with many contributing factors. The concept of PTSD has continued to evolve over time. A diagnosis of PTSD may be hard to get right. Studies suggest a wide variation in its presentation and diagnostic stability. It is tempting to explore the possibility of using chemicals that could...
South African Journal of Psychiatry
2024
Vidette M Juby, Saaeda Paruk, Mitsuaki Tomita et al.
3 citations
There is currently no published evidence demonstrating the effectiveness and safety of subanaesthetic doses of ketamine, when administered intravenously as an adjunct treatment for depressive symptoms, in a real world setting in South Africa. This retrospective chart review reports the clinical response (change in Patient Health Questionnaire - 7 score) to an initial infusion series of ketamine...
NeuroImage: Clinical
2024
Antje Opitz, Josua Zimmermann, David M. Cole et al.
2 citations
In stimulant use and addiction, conflict control processes are crucial for regulating substance use and sustaining abstinence, which can be particularly challenging in social-affective situations. Users of methamphetamine (METH, "Ice") and 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") both experience impulse control deficits, but display different social-affective and addictive profiles....
Frontiers in Pharmacology
2024
Senbing Zhang, Yanzhu Pu, Jianning Liu et al.
12 citations
(R, S)- and (S)-ketamine have made significant progress in the treatment of treatment-resistant depression (TRD) and have become a research focus in recent years. However, they both have risks of psychomimetic effects, dissociative effects, and abuse liability, which limit their clinical use. Recent preclinical and clinical studies have shown that (R)-ketamine has a more efficient and lasting...
Frontiers in Psychiatry
2024
Matteo Di Vincenzo, Vassilis Martiadis, Bianca Della Rocca et al.
31 citations
Treatment-resistant depression (TRD) occurs when at least two different antidepressants, taken at the right dosage, for adequate period of time and with continuity, fail to give positive clinical effects. Esketamine, the S-enantiomer of ketamine, was recently approved for TRD treatment from U.S. Food and Drug Administration and European Medicine Agency. Despite proved clinical efficacy, many...
Frontiers in Molecular Neuroscience
2024
Jia-Ren Liu, Xiao Hui Han, Koichi Yuki et al.
4 citations
Disrupted in schizophrenia-1 (DISC1) is a scaffolding protein whose mutated form has been linked to schizophrenia, bipolar affective disorders, and recurrent major depression. DISC1 regulates multiple signaling pathways involved in neurite outgrowth and cortical development and binds directly to glycogen synthase kinase-3β (GSK-3β). Since ketamine activates GSK-3β, we examined the impact of...